Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)‘s stock had its “hold” rating reissued by equities researchers at Jefferies Group LLC in a note issued to investors on Sunday. They currently have a $25.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $28.00. Jefferies Group LLC’s price objective points to a potential upside of 7.94% from the stock’s current price.

A number of other brokerages have also recently commented on SBRA. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Tuesday, June 20th. Mizuho reaffirmed a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th. Zacks Investment Research lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Thursday, June 8th. Canaccord Genuity reiterated a “hold” rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $30.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, May 8th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. Sabra Healthcare REIT currently has an average rating of “Hold” and an average target price of $27.29.

Sabra Healthcare REIT (NASDAQ SBRA) opened at 23.16 on Friday. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a net margin of 40.22% and a return on equity of 10.35%. The business had revenue of $62.65 million for the quarter, compared to analysts’ expectations of $63.47 million. During the same period in the prior year, the company posted $0.54 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. On average, analysts expect that Sabra Healthcare REIT will post $1.20 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/07/09/sabra-healthcare-reits-nasdaqsbra-hold-rating-reiterated-at-jefferies-group-llc.html.

Several institutional investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares during the last quarter. Bank of Montreal Can raised its position in shares of Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares in the last quarter. Russell Investments Group Ltd. bought a new position in shares of Sabra Healthcare REIT during the fourth quarter worth $120,000. Ameritas Investment Partners Inc. bought a new position in shares of Sabra Healthcare REIT during the first quarter worth $156,000. Finally, Stratos Wealth Partners LTD. bought a new position in shares of Sabra Healthcare REIT during the first quarter worth $207,000. Institutional investors and hedge funds own 99.47% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.